MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Indian ARSACS (Autosomal Recessive Spastic Ataxia of Charlevoix- Saugenay): Clinical report of the first genetically proven case from India, due to a novel SACS duplication

P. Agarwal (Mumbai, India)

Meeting: 2017 International Congress

Abstract Number: 813

Keywords: Ataxia: Genetics

Session Information

Date: Wednesday, June 7, 2017

Session Title: Ataxia

Session Time: 1:15pm-2:45pm

Location: Exhibit Hall C

Objective:  

Objective: To report clinical, imaging and genetic findings in a case of ARSACS from India

Background: ARSACS was described initially from Quebec, Canada, and later from few other countries, but there is no clinical report of a genetically proven case from India. We report a case from Western India with typical clinical and imaging features, that was subsequently found to harbor a novel duplication in the SACS gene.

 

Methods: Clinical, imaging and genetic descriptive Case report

Results: A 12-year old boy presented with difficulty walking and poor balance since age 4, mild delay in reaching motor milestones and poor scholastic performance. Family history was negative , with no parental consanguinity. Extraocular movements were abnormal with saccadic pursuit, and normal saccades. Speech had a spastic and ataxic quality. Dysmetria and ataxia were present in upper limbs. Gait was ataxic, with difficulty walking tandem. Pes cavus was present. Deep tendon reflexes were absent in legs.  Biochemical workup for alternative causes of ataxia was negative, as was gene testing for FA.  MRI showed cerebellar superior vermian atrophy [Figure 1], linear ‘striped’ pontine hypointensities [Figure 2], and thickened middle cerebellar peduncles. EMG showed severe axonal and demyelinating neuropathy in all limbs, with absent SNAPs in legs, reduced CMAPs and low velocities. Funduscopic examination revealed myelinated nerve fibers radiating from optic disc and embedding retinal vessels. [Figure 3] Optical coherence tomogram showed thickening of retinal nerve fiber layer.

          

            Targeted gene testing for a SACS gene mutation showed a homozygous four base pair duplication in exon 10 of the gene (chr13:23906322-23906325dupTCAC; Depth: 419x) that resulted in a frameshift and premature truncation of the protein 2 amino acids downstream to codon 3898 (p.Asp3898GlufsTer2; ENST00000382298) that was of pathogenic significance. The parents were both heterozygous for the same four-base pair duplication, providing further proof of pathogenicity.

Conclusions: This first clinical and genetically confirmed report of Indian ARSACS reinforces the view that this rare inherited ataxia has a typical, possibly unique combination of clinical, electrophysiologic, and imaging findings that can alert clinicians to the diagnosis in young-onset recessive ataxia.

 

References:

  1. Duquette A, Brais B, Bouchard JP, Mathieu J. Mov Disord. Clinical presentation and early evolution of spastic ataxia of Charlevoix-Saguenay. 2013 Dec;28(14):2011-4.
  2. Martin MH, Bouchard JP, Sylvain M, St-Onge O, Truchon S. Autosomal recessive spastic ataxia of Charlevoix-Saguenay: a report of MR imaging in 5 patients. AJNR Am J Neuroradiol. 2007 Sep;28(8):1606-8.

To cite this abstract in AMA style:

P. Agarwal. Indian ARSACS (Autosomal Recessive Spastic Ataxia of Charlevoix- Saugenay): Clinical report of the first genetically proven case from India, due to a novel SACS duplication [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/indian-arsacs-autosomal-recessive-spastic-ataxia-of-charlevoix-saugenay-clinical-report-of-the-first-genetically-proven-case-from-india-due-to-a-novel-sacs-duplication/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/indian-arsacs-autosomal-recessive-spastic-ataxia-of-charlevoix-saugenay-clinical-report-of-the-first-genetically-proven-case-from-india-due-to-a-novel-sacs-duplication/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley